Hongchang International Co., Ltd
HCILOTCHealthcare · Electromedical & Electrotherapeutic Apparatus · NV · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | |
|---|---|---|---|---|---|---|
| Revenue | $2.9M | $2.7M | $78,953 | $96,478 | $222,701 | $163,680 |
| Operating income | −$383,326 | −$469,572 | −$239,992 | −$162,836 | −$278,783 | −$538,124 |
| Net income | −$472,393 | −$378,794 | −$239,989 | −$163,020 | −$548,396 | −$488,386 |
| Total assets | $57.5M | $50.2M | $31.2M | $93,549 | $194,294 | $852,453 |
| Total liabilities | $18.7M | $9.7M | $31.7M | $1.9M | $1.8M | $1.6M |
| Equity | $38.8M | $40.5M | −$418,653 | −$193,756 | −$1.4M | −$715,870 |
| EPS (diluted) | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Shares out. | 518.8M | 1.03B | 1.03B | 1.03B | 1.03B | 1.03B |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2024- Operating margin
- −13.4%
- Net margin
- −16.5%
- Return on equity
- −1.2%
- Return on assets
- −0.8%
- Return on capital (ROCE)
- −0.8%
- Liabilities / assets
- 32.5%
- Debt / equity
- 0.48×
- Book value / share
- $0.07
- Revenue growth (YoY)
- 7.1%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2024- Altman Z″ (distress)
- 2.23grey zone
- Accruals / assets
- 11.9%high accruals
- Beneish M-Score
- -3.26normal
- Piotroski F-Score
- 2/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 5 warning● 2 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Negative operating cash flow
- High accruals — earnings-quality risk
- Altman Z″ in the grey zone
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Aug 15, 2023
- NT 10-Qmissed a reporting deadline ↗May 16, 2022
- NT 10-Kmissed a reporting deadline ↗Apr 1, 2022
- NT 10-Kmissed a reporting deadline ↗Apr 2, 2021
- NT 10-Kmissed a reporting deadline ↗Mar 30, 2016
- NT 10-Qmissed a reporting deadline ↗May 16, 2012
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 88 | 1.0 | 0.0% |
| Apr 30, 2026 | 88 | 1.3 | +1.1% |
| Apr 15, 2026 | 87 | 1.5 | 0.0% |
| Mar 31, 2026 | 87 | 1.0 | 0.0% |
| Mar 13, 2026 | 87 | 29.0 | 0.0% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Amended charter or bylawsMay 13, 2025
- Changed auditor · Director / officer changeApr 30, 2025
- Director / officer changeMay 8, 2024
- Director / officer changeApr 1, 2024
- Other material eventNov 28, 2023
- Amended charter or bylawsNov 24, 2023
- Amended charter or bylawsNov 21, 2023
- Entered a material agreement · Completed an acquisition or disposition · Unregistered equity sale · Change in control · Director / officer changeSep 7, 2023
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 10-QQUARTERLY REPORTFeb 13, 2026
- 144Jan 22, 2026
- 10-QQUARTERLY REPORTNov 13, 2025
- 10-QQUARTERLY REPORTAug 14, 2025
- 10-KTTRANSITION REPORTAug 11, 2025
- 8-KCURRENT REPORTMay 13, 2025
- 8-KCURRENT REPORTApr 30, 2025
- 10-KANNUAL REPORTMar 28, 2025
- 10-QQUARTERLY REPORTNov 13, 2024
- 8-K/AAMENDMENT NO. 1 TO FORM 8-KAug 28, 2024
- 10-QQUARTERLY REPORTAug 13, 2024
- 10-QQUARTERLY REPORTMay 15, 2024
- 8-KCURRENT REPORTMay 8, 2024
- 10-KANNUAL REPORTApr 1, 2024
- 8-KCURRENT REPORTApr 1, 2024
Event-driven situations (2)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.